One hypothesis in the paper was that lower doses may be the reason some studies have shown benefit. If the paper has merit about the risks of curcumin than the poor bioavailability may be a plus.
I started trying to add some in my diet as a spice not a pill so I am probably taking extremely small amounts and I take it in the hopes of helping (preventing deterioration) in cognition rather than some of the reported anti-cancer properties.
Market Data 
Markets 
AI
